Skip to main content
Top
Published in: Clinical Rheumatology 2/2008

01-02-2008 | Original Article

Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch–Schönlein purpura

Authors: Aydın Ece, Selvi Kelekçi, Halil Kocamaz, Aşkın Hekimoğlu, Hasan Balık, İlyas Yolbaş, Özcan Erel

Published in: Clinical Rheumatology | Issue 2/2008

Login to get access

Abstract

The aim of this study was to assess the role of oxidative stress in the pathogenesis of Henoch–Schönlein purpura (HSP) vasculitis. The activities of catalase (CAT), arylesterase (ARYL), and paraoxonase (PON) as antioxidant enzymes and serum malondialdehyde (MDA) level as an indicator of lipid peroxidation, together with total antioxidant status (TAS), were measured in 29 children with HSP (mean age 9.3 ± 2.7 years), both at the onset of the disease and at the remission period and in matched controls. Active-stage HSP had significantly higher MDA level (15.5 ± 7.3 vs 7.8 ± 3.9 nmol/l, respectively, P < 0.001) and lower TAS (524 ± 122 vs 699 ± 122 μmol Trolox Equiv/l, P < 0.001), PON (97 ± 47 vs 136 ± 95 U/l, P = 0.042), ARYL (158 ± 39 vs 212 ± 52 U/l, P < 0.001), and CAT (50 ± 27 vs 69 ± 20 U/l, P = 0.002) activities compared with the control subjects. Although CAT (P > 0.05) and PON (P > 0.05) activities were found to be similar between active and remission stages of HSP, the active stage of the disease had significantly lower ARYL (P = 0.011) and TAS (P = 0.006) and higher MDA (P < 0.001) values compared with remission period. Significant positive correlations were found between CAT and MDA (r = 0.433, P = 0.019) and between CAT and C-reactive protein (r = 0.386, P = 0.035) in the active stage of HSP. No significant differences were detected in oxidant/antioxidant parameters between patients with or without renal, gastrointestinal, or joint involvement (P > 0.05). Increased oxidative stress and lipid peroxidation may play important roles in the pathogenesis of HSP vasculitis. Antioxidant therapeutic interventions in long-lasting vasculitis and risk of atherosclerosis secondary to increased oxidant stress remain to be investigated.
Literature
1.
go back to reference Buyan N, Erbas D, Akkok N et al (1998) Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch–Schonlein Purpura. Prostaglandins Leukot Essent Fat Acids 59:181–184CrossRef Buyan N, Erbas D, Akkok N et al (1998) Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch–Schonlein Purpura. Prostaglandins Leukot Essent Fat Acids 59:181–184CrossRef
2.
go back to reference McCord JM (1993) Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 26:351–357PubMedCrossRef McCord JM (1993) Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 26:351–357PubMedCrossRef
3.
go back to reference Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724PubMedCrossRef Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724PubMedCrossRef
4.
go back to reference Demircin G, Öner A, Ünver Y et al (1998) Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch–Schönlein purpura. Acta Pediatr 87:848–852CrossRef Demircin G, Öner A, Ünver Y et al (1998) Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch–Schönlein purpura. Acta Pediatr 87:848–852CrossRef
5.
go back to reference Erdoğan Ö, Öner A, Aydın A et al (2003) Effect of vitamin E treatment on the oxidative damage occurring in Henoch–Schönlein purpura. Acta Paediatr 92:546–550PubMedCrossRef Erdoğan Ö, Öner A, Aydın A et al (2003) Effect of vitamin E treatment on the oxidative damage occurring in Henoch–Schönlein purpura. Acta Paediatr 92:546–550PubMedCrossRef
6.
go back to reference Shah SV (1988) Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 254:F337–F344PubMed Shah SV (1988) Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 254:F337–F344PubMed
7.
go back to reference Rahman MA, Emancipator SS, Sedor JR (1988) Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis. J Lab Clin Med 112:619–626PubMed Rahman MA, Emancipator SS, Sedor JR (1988) Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis. J Lab Clin Med 112:619–626PubMed
8.
go back to reference Turi S, Nemeth I, Torkos A et al (1997) Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22:161–168PubMedCrossRef Turi S, Nemeth I, Torkos A et al (1997) Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22:161–168PubMedCrossRef
9.
go back to reference Cao G, Prior RL (1998) Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 44:1309–1315PubMed Cao G, Prior RL (1998) Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 44:1309–1315PubMed
10.
go back to reference Rice-Evans C, Miller NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234:279–293PubMedCrossRef Rice-Evans C, Miller NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234:279–293PubMedCrossRef
11.
go back to reference Janero DR (1990) Malondialdehyde and thiobarbituric-acid reactivity as diagnostic indices of lipid peroxidation, and peroxidative tissue injury. Free Radic Biol Med 9:515–540PubMedCrossRef Janero DR (1990) Malondialdehyde and thiobarbituric-acid reactivity as diagnostic indices of lipid peroxidation, and peroxidative tissue injury. Free Radic Biol Med 9:515–540PubMedCrossRef
12.
go back to reference Nielsen F, Mikkelsen BB, Nielsen JB et al (1997) Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 43:1209–1214PubMed Nielsen F, Mikkelsen BB, Nielsen JB et al (1997) Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 43:1209–1214PubMed
13.
go back to reference Aviram M, Rosenblat M, Billecke S et al (1999) Human serum paraoxonase (PON) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26:892–904PubMedCrossRef Aviram M, Rosenblat M, Billecke S et al (1999) Human serum paraoxonase (PON) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26:892–904PubMedCrossRef
14.
go back to reference Aviram M, Rosenblat M (2005) Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 16:393–399PubMedCrossRef Aviram M, Rosenblat M (2005) Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 16:393–399PubMedCrossRef
15.
go back to reference Mills JA, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch–Schönlein purpura. Arthritis Rheum 33:1114–1121PubMedCrossRef Mills JA, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch–Schönlein purpura. Arthritis Rheum 33:1114–1121PubMedCrossRef
16.
go back to reference Goth L (1991) A simple method for determination of serum catalase activity and revision of reference range. Clin Chem Acta 196:143–151CrossRef Goth L (1991) A simple method for determination of serum catalase activity and revision of reference range. Clin Chem Acta 196:143–151CrossRef
17.
go back to reference Furlong CE, Richter RJ, Seidel SL et al (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242–247PubMedCrossRef Furlong CE, Richter RJ, Seidel SL et al (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242–247PubMedCrossRef
18.
go back to reference Haagen L, Brock A (1992) A new automated method for phenotyping arylesterase (E.C.3·1·1·2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 30:391–395PubMed Haagen L, Brock A (1992) A new automated method for phenotyping arylesterase (E.C.3·1·1·2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 30:391–395PubMed
19.
go back to reference Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119PubMedCrossRef Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119PubMedCrossRef
20.
go back to reference Asakawa T, Matsushita S (1980) Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 15:137–141CrossRef Asakawa T, Matsushita S (1980) Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 15:137–141CrossRef
21.
go back to reference Al-Sheyyab M, El-Shanti H, Ajlouni S et al (1996) Henoch–Schönlein purpura: clinical experience and contemplation on a streptococcal association. J Trop Pediatr 42:200–203PubMedCrossRef Al-Sheyyab M, El-Shanti H, Ajlouni S et al (1996) Henoch–Schönlein purpura: clinical experience and contemplation on a streptococcal association. J Trop Pediatr 42:200–203PubMedCrossRef
22.
go back to reference Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47:412–426PubMed Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47:412–426PubMed
23.
go back to reference Minuz P, Fava C, Cominacini L (2006) Oxidative stress, antioxidants, and vascular damage. Br J Clin Pharmacol 61:774–777PubMedCrossRef Minuz P, Fava C, Cominacini L (2006) Oxidative stress, antioxidants, and vascular damage. Br J Clin Pharmacol 61:774–777PubMedCrossRef
24.
go back to reference Öner A, Tınaztepe K, Erdoğan Ö (1995) The effect of triple therapy on rapidly progressive type of Henoch–Schönlein nephritis. Pediatr Nephrol 9:6–10PubMedCrossRef Öner A, Tınaztepe K, Erdoğan Ö (1995) The effect of triple therapy on rapidly progressive type of Henoch–Schönlein nephritis. Pediatr Nephrol 9:6–10PubMedCrossRef
25.
go back to reference Iuchi T, Akaike M, Mitsui T et al (2003) Glucorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81–87PubMedCrossRef Iuchi T, Akaike M, Mitsui T et al (2003) Glucorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81–87PubMedCrossRef
26.
go back to reference Ece A, Atamer Y, Gürkan F et al (2005) Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1279–1284PubMedCrossRef Ece A, Atamer Y, Gürkan F et al (2005) Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1279–1284PubMedCrossRef
27.
go back to reference Harper L, Nuttall SL, Martin U, Savage CO (2002) Adjuvant treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils. Rheumatology (Oxford) 41:274–278CrossRef Harper L, Nuttall SL, Martin U, Savage CO (2002) Adjuvant treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils. Rheumatology (Oxford) 41:274–278CrossRef
Metadata
Title
Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch–Schönlein purpura
Authors
Aydın Ece
Selvi Kelekçi
Halil Kocamaz
Aşkın Hekimoğlu
Hasan Balık
İlyas Yolbaş
Özcan Erel
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0671-5

Other articles of this Issue 2/2008

Clinical Rheumatology 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.